Atlas FDA

Elecsys Anti-HBc II

FDA premarket approval P100031/S027 · decided 2022-04-04

Approval details

PMA number
P100031
Supplement
S027
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Elecsys Anti-HBc II
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Roche Diagnostics Corp.
Date received
2021-09-30
Decision date
2022-04-04
Days to decision
186 days
Decision code
APPR
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Indianapolis, IN
Statement
Approval for modification of the assay reagents to improve the tolerance to biotin interference, updating the sample stability claims, and revisions to the device labeling.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SUPER SANI-CLOTH/ ACCU-CHEK INFORM II SYSTEM (K130138)Roche Diagnostics Corp.2013-03-15
ELECSYS CA 19-9 CALCHECK 5 (K101365)Roche Diagnostics Corp.2010-10-05
COBAS 8000 MODULAR SERIES ANALYZER (K100853)Roche Diagnostics Corp.2010-09-09
ACCU-CHEK ULTRFLEX INFUSION SET (K101196)Roche Diagnostics Corp.2010-08-27
AMPHETAMINES II ASSAY (K093664)Roche Diagnostics Corp.2010-07-28
ELECSYS INSULIN CALCHECK 5 (K101075)Roche Diagnostics Corp.2010-06-11
ELECSYS TESTOSTERONE II IMMUNOASSAY (K093421)Roche Diagnostics Corp.2010-04-23
ELECSYS TROPONIN T CALCHECK 5 (K092848)Roche Diagnostics Corp.2010-03-19